Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA’s CDER Is Fostering Use Of Artificial Intelligence In Drug Development
Mar 01 2023
•
By
Brenda Sandburg
FDA is focusing on use of artificial intelligence and machine learning to enhance drug development • Source: Shutterstock
More from AI
More from Advanced Technologies